Aug 2026· Probiotics and Antimicrobial Proteins· 0 citations· 91 references
Medicine
TL;DR
This review aimed to synthesise the current evidence on PAP mechanisms, host-modulatory effects, and translational perspectives to present exciting avenues for clinical deployment of solutions in the early stages of development.
Overall, LAB-derived bacteriocins have the most substantial evidence for production, characterization, and safety, while NGP-associated systems are promising but mostly preclinical and need further structural and functional validation.
Vishakha Tyagi, Ajay Kumar, N. Thapliyal et al.· Applied microbiology· 0 citations
This review collates the existing literature on zoonotic and bacterial origin AMPs, along with the matrix-disrupting and quorum-quenching enzymes, highlighting those which have proven to be effective in vitro/in vivo against clinical isolates from patients and identifies specific physiological and challenges that need...
S. Shukla, B. D. Iyer· Critical reviews in microbio...· 0 citations
Antimicrobial peptides (AMPs) have been extensively investigated as alternatives to conventional antibiotics to combat multidrug-resistant bacteria. This narrow antibiotic-replacement framework underestimates the biological and translational potential of AMPs. The present review reframes them as disease-context-depende...
Min-Ho Lee· Journal of Microbiology and...· 0 citations
Overall, plant-derived therapeutics represent a promising and sustainable avenue for the discovery and development of complementary antimicrobial strategies to address the growing global burden of AMR.
Deeksha Rathor, Pushpendra Kumar, Km. Neha et al.· GLOBAL JOURNAL OF PHARMACEUT...· 0 citations
Antibiotic resistance has emerged as a critical threat to global health, food security, and economic stability due to the overuse of antibiotics in human medicine and livestock production. This review examines the mechanisms of antibiotic action and resistance, clinical and environmental consequences of resistance, and...
Haruna Abdullahi, Haliru Ahmad Kabiru, Habila Mamman Paul et al.· FUDMA Journal of Sciences· 0 citations
Existing evidence does not support classifying defensins as resistance-proof or uniformly less resistance-prone than conventional antibiotics, so they should be regarded as versatile scaffolds whose resistance risk requires candidate-specific evaluation.
E. Abdallah, S. Al-Mijalli, N. al Hakawati et al.· Frontiers in Cellular and In...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.